<p>The present invention relates to methods of treating subjects suffering from pre-hypertension or hypertension by administering to a subject in need of treatment thereof a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.</p>
申请公布号
EP1940397(A2)
申请公布日期
2008.07.09
申请号
EP20060774718
申请日期
2006.08.02
申请人
TAP PHARMACEUTICAL PRODUCTS, INC.
发明人
LADEMACHER, CHRISTOPHER;ZHAO, LIN;JOSEPH-RIDGE, NANCY;JOHNSON, ROBERT
